Cheryl Chan
Advises on public and private mergers and acquisitions, investments and joint ventures, and governance and activism. One of The Deal’s 2023 “Top Women in Dealmaking.”
Cheryl advises U.S. and international clients on public and private mergers and acquisitions, investments, joint ventures, corporate governance, shareholder activism and other general corporate matters. She also represents private equity firms and their portfolio companies on a full range of transactions, including acquisitions and dispositions of investments, leveraged buyouts and minority investments.
The Deal recognized Cheryl as one of the “Top Women in Dealmaking” in 2021, 2022 and 2023, after profiling her as a “Rising Star” in 2020. Cheryl was named a finalist for the American Lawyer’s “Corporate Attorney of the Year” award.
She is a Global Advisory Board Member of the Women in Law Empowerment Forum.
Experience
Public Company and Take Private Transactions
- Emerson on its:
- majority investment in and subsequent proposal to acquire Aspen Technology at a $15.3 billion enterprise valuation
- $8.2 billion acquisition of National Instruments
- Gilead on its:
- $21 billion acquisition of Immunomedics
- $4.3 billion acquisition of CymaBay Therapeutics
- Brookfield Business Partners’ $8.3 billion take private acquisition of CDK Global
- Arcadium Lithium on its $6.7 billion acquisition by Rio Tinto
- Owens Corning on its $3.9 billion acquisition of Masonite International
- Alcoa on its $2.2 billion acquisition of Alumina
- Livent’s $10.6 billion merger of equals with Allkem
- SS&C Technologies on its $5.4 billion acquisition of DST Systems
- HP on its $3.3 billion acquisition of Poly
- Arco Platform on its $1.5 billion going-private transaction
- Bath & Body Works in the Victoria’s Secret spinoff
- FTS International on its $407 million acquisition by ProFrac Holdings
Private Equity Transactions
- Brookfield Business Partners on its:
- $13.2 billion acquisition of the Power Solutions business of Johnson Controls
- $8.3 billion acquisition of CDK Global
- $3.4 billion acquisition of DexKo Global and DexKo’s acquisition of the TexTrail businesses
- Emerson’s sale of control of the Climate Technologies business in a $14 billion transaction to Blackstone funds
- Emerson’s sale of its Therm-O-Disc business to One Rock Capital Partners
- TIAA on its sale of TIAA Bank to private equity buyers
- Atairos on a series of transactions involving Learfield IMG College
Healthcare and Life Sciences
- Gilead on its:
- $21 billion acquisition of Immunomedics
- $4.3 billion acquisition of CymaBay Therapeutics
- $405 million acquisition of MiroBio
- Shire on its acquisition of Foresight Biotherapeutics
Industrials and Energy
- Emerson on its:
- sale of control of the Climate Technologies business in a $14 billion transaction
- majority investment in and subsequent proposal to acquire Aspen Technology at a $15.3 billion enterprise valuation
- $8.2 billion acquisition of National Instruments
- Owens Corning on its $3.9 billion acquisition of Masonite International
- Alcoa on its $2.2 billion acquisition of Alumina
- DexKo Global on its acquisition of the TexTrail businesses
- Livent on its:
- $10.6 billion merger of equals with Allkem
- investment in Nemaska Lithium
- Spectrum Brands on the $4.3 billion sale of its Hardware & Home Improvement segment to ASSA ABLOY
Insights
News
Recognition
The Deal – “Top Women in Dealmaking,” M&A, 2021, 2022 and 2023
American Lawyer - “Corporate Attorney of the Year” finalist, 2022
IFLR1000 – M&A, United States, Rising Star Partner
The Deal – “Top Rising Stars: Class of 2021”
The Deal – “Rising Star,” 2020
Education
- cum laude
- summa cum laude
- Phi Beta Kappa
Qualifications and admissions
- State of New York